Sign in
8-K/A

Current Report

Lyell Immunopharma, Inc. Filed Acc 0001628280-25-001065

Exhibits

  • Item 9.01 Financial statements and exhibits

From the SEC's structured data for this filing

Loading lyel-20241031.htm…